Selected research
Industry Research
Robotic IV Compounding System Industry Research Report 2026
Market perspective
The global Robotic IV Compounding System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Robotic IV Compounding System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Robotic IV Compounding System is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Robotic IV Compounding System is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Robotic IV Compounding System include Weibond Technology, Sanggu, Lachsis, General Healthy, Shenzhen Broadcare Robots, Baxter, Steriline, Omnicell and NewIcon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Robotic IV Compounding System market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Robotic IV Compounding System Market by Company
Weibond Technology
Sanggu
Lachsis
General Healthy
Shenzhen Broadcare Robots
Baxter
Steriline
Omnicell
NewIcon
Kapsam Health Products
ICU Medical
Grifols
Comecer
Arxium
Robotic IV Compounding System Segment by Type
Closed System
Non-closed System
Robotic IV Compounding System Segment by Application
Hazardous Drugs
Non-hazardous Drugs
Robotic IV Compounding System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Robotic IV Compounding System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Robotic IV Compounding System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Robotic IV Compounding System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Robotic IV Compounding System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Robotic IV Compounding System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Robotic IV Compounding System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Closed System
- Non-closed System
Applications
- Hazardous Drugs
- Non-hazardous Drugs
Companies covered
- Weibond Technology
- Sanggu
- Lachsis
- General Healthy
- Shenzhen Broadcare Robots
- Baxter
- Steriline
- Omnicell
- NewIcon
- Kapsam Health Products
- ICU Medical
- Grifols
- Comecer
- Arxium
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Robotic IV Compounding System Market Size (2021-2032)
- 2.2.2 Global Robotic IV Compounding System Sales (2021-2032)
- 2.2.3 Global Robotic IV Compounding System Market Average Price (2021-2032)
- 2.3 Robotic IV Compounding System by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Closed System
- 2.3.3 Non-closed System
- 2.4 Robotic IV Compounding System by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hazardous Drugs
- 2.4.3 Non-hazardous Drugs
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Robotic IV Compounding System Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Robotic IV Compounding System Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Robotic IV Compounding System Revenue of Manufacturers (2021-2026)
- 3.4 Global Robotic IV Compounding System Average Price by Manufacturers (2021-2026)
- 3.5 Global Robotic IV Compounding System Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Robotic IV Compounding System, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Robotic IV Compounding System, Product Type & Application
- 3.8 Global Manufacturers of Robotic IV Compounding System, Established Date
- 3.9 Global Robotic IV Compounding System Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Weibond Technology
- 4.1.1 Weibond Technology Company Information
- 4.1.2 Weibond Technology Business Overview
- 4.1.3 Weibond Technology Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Weibond Technology Robotic IV Compounding System Product Portfolio
- 4.1.5 Weibond Technology Recent Developments
- 4.2 Sanggu
- 4.2.1 Sanggu Company Information
- 4.2.2 Sanggu Business Overview
- 4.2.3 Sanggu Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanggu Robotic IV Compounding System Product Portfolio
- 4.2.5 Sanggu Recent Developments
- 4.3 Lachsis
- 4.3.1 Lachsis Company Information
- 4.3.2 Lachsis Business Overview
- 4.3.3 Lachsis Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lachsis Robotic IV Compounding System Product Portfolio
- 4.3.5 Lachsis Recent Developments
- 4.4 General Healthy
- 4.4.1 General Healthy Company Information
- 4.4.2 General Healthy Business Overview
- 4.4.3 General Healthy Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 General Healthy Robotic IV Compounding System Product Portfolio
- 4.4.5 General Healthy Recent Developments
- 4.5 Shenzhen Broadcare Robots
- 4.5.1 Shenzhen Broadcare Robots Company Information
- 4.5.2 Shenzhen Broadcare Robots Business Overview
- 4.5.3 Shenzhen Broadcare Robots Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shenzhen Broadcare Robots Robotic IV Compounding System Product Portfolio
- 4.5.5 Shenzhen Broadcare Robots Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Robotic IV Compounding System Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 Steriline
- 4.7.1 Steriline Company Information
- 4.7.2 Steriline Business Overview
- 4.7.3 Steriline Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Steriline Robotic IV Compounding System Product Portfolio
- 4.7.5 Steriline Recent Developments
- 4.8 Omnicell
- 4.8.1 Omnicell Company Information
- 4.8.2 Omnicell Business Overview
- 4.8.3 Omnicell Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Omnicell Robotic IV Compounding System Product Portfolio
- 4.8.5 Omnicell Recent Developments
- 4.9 NewIcon
- 4.9.1 NewIcon Company Information
- 4.9.2 NewIcon Business Overview
- 4.9.3 NewIcon Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 NewIcon Robotic IV Compounding System Product Portfolio
- 4.9.5 NewIcon Recent Developments
- 4.10 Kapsam Health Products
- 4.10.1 Kapsam Health Products Company Information
- 4.10.2 Kapsam Health Products Business Overview
- 4.10.3 Kapsam Health Products Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kapsam Health Products Robotic IV Compounding System Product Portfolio
- 4.10.5 Kapsam Health Products Recent Developments
- 4.11 ICU Medical
- 4.11.1 ICU Medical Company Information
- 4.11.2 ICU Medical Business Overview
- 4.11.3 ICU Medical Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ICU Medical Robotic IV Compounding System Product Portfolio
- 4.11.5 ICU Medical Recent Developments
- 4.12 Grifols
- 4.12.1 Grifols Company Information
- 4.12.2 Grifols Business Overview
- 4.12.3 Grifols Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Grifols Robotic IV Compounding System Product Portfolio
- 4.12.5 Grifols Recent Developments
- 4.13 Comecer
- 4.13.1 Comecer Company Information
- 4.13.2 Comecer Business Overview
- 4.13.3 Comecer Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Comecer Robotic IV Compounding System Product Portfolio
- 4.13.5 Comecer Recent Developments
- 4.14 Arxium
- 4.14.1 Arxium Company Information
- 4.14.2 Arxium Business Overview
- 4.14.3 Arxium Robotic IV Compounding System Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Arxium Robotic IV Compounding System Product Portfolio
- 4.14.5 Arxium Recent Developments
5 Global Robotic IV Compounding System Market Scenario by Region
- 5.1 Global Robotic IV Compounding System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Robotic IV Compounding System Sales by Region: 2021-2032
- 5.2.1 Global Robotic IV Compounding System Sales by Region: 2021-2026
- 5.2.2 Global Robotic IV Compounding System Sales by Region: 2027-2032
- 5.3 Global Robotic IV Compounding System Revenue by Region: 2021-2032
- 5.3.1 Global Robotic IV Compounding System Revenue by Region: 2021-2026
- 5.3.2 Global Robotic IV Compounding System Revenue by Region: 2027-2032
- 5.4 North America Robotic IV Compounding System Market Facts & Figures by Country
- 5.4.1 North America Robotic IV Compounding System Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Robotic IV Compounding System Sales by Country (2021-2032)
- 5.4.3 North America Robotic IV Compounding System Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Robotic IV Compounding System Market Facts & Figures by Country
- 5.5.1 Europe Robotic IV Compounding System Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Robotic IV Compounding System Sales by Country (2021-2032)
- 5.5.3 Europe Robotic IV Compounding System Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Robotic IV Compounding System Market Facts & Figures by Country
- 5.6.1 Asia Pacific Robotic IV Compounding System Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Robotic IV Compounding System Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Robotic IV Compounding System Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Robotic IV Compounding System Market Facts & Figures by Country
- 5.7.1 South America Robotic IV Compounding System Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Robotic IV Compounding System Sales by Country (2021-2032)
- 5.7.3 South America Robotic IV Compounding System Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Robotic IV Compounding System Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Robotic IV Compounding System Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Robotic IV Compounding System Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Robotic IV Compounding System Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Robotic IV Compounding System Sales by Type (2021-2032)
- 6.1.1 Global Robotic IV Compounding System Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Robotic IV Compounding System Sales Market Share by Type (2021-2032)
- 6.2 Global Robotic IV Compounding System Revenue by Type (2021-2032)
- 6.2.1 Global Robotic IV Compounding System Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Robotic IV Compounding System Revenue Market Share by Type (2021-2032)
- 6.3 Global Robotic IV Compounding System Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Robotic IV Compounding System Sales by Application (2021-2032)
- 7.1.1 Global Robotic IV Compounding System Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Robotic IV Compounding System Sales Market Share by Application (2021-2032)
- 7.2 Global Robotic IV Compounding System Revenue by Application (2021-2032)
- 7.2.1 Global Robotic IV Compounding System Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Robotic IV Compounding System Revenue Market Share by Application (2021-2032)
- 7.3 Global Robotic IV Compounding System Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Robotic IV Compounding System Value Chain Analysis
- 8.1.1 Robotic IV Compounding System Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Robotic IV Compounding System Production Mode & Process
- 8.2 Robotic IV Compounding System Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Robotic IV Compounding System Distributors
- 8.2.3 Robotic IV Compounding System Customers
9 Global Robotic IV Compounding System Analyzing Market Dynamics
- 9.1 Robotic IV Compounding System Industry Trends
- 9.2 Robotic IV Compounding System Industry Drivers
- 9.3 Robotic IV Compounding System Industry Opportunities and Challenges
- 9.4 Robotic IV Compounding System Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst